Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy, safety and pharmacokinetics of BIRB 796 BS tablets in patients with active rheumatoid arthritis; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BIRB 796 BS Tablets (BIRB 796)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: TERMINATED